These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1835069)

  • 1. [Antibacterial effect in vitro of Bifidobacterium longum on gram-negative bacilli of the fecal flora].
    Perney P; Lamaury I; Perez C; Jonquet O; Gouttebel MC; Astre C; Joyeux H
    Presse Med; 1991 Oct; 20(32):1571. PubMed ID: 1835069
    [No Abstract]   [Full Text] [Related]  

  • 2. Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species.
    Sakata S; Tonooka T; Ishizeki S; Takada M; Sakamoto M; Fukuyama M; Benno Y
    FEMS Microbiol Lett; 2005 Feb; 243(2):417-23. PubMed ID: 15686844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial resistance, Wayampis Amerindians, French Guyana.
    Grenet K; Guillemot D; Jarlier V; Moreau B; Dubourdieu S; Ruimy R; Armand-Lefevre L; Bau P; Andremont A
    Emerg Infect Dis; 2004 Jun; 10(6):1150-3. PubMed ID: 15207074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-specific composition and succession of Bifidobacterium longum in human feces.
    Kohara T; Hayashi S; Hamatsuka J; Nishitani Y; Masuda Y; Osawa R
    Syst Appl Microbiol; 2007 Mar; 30(2):165-8. PubMed ID: 16876367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus).
    Miller LG; Finegold SM
    J Bacteriol; 1967 Jan; 93(1):125-30. PubMed ID: 6020399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of Bifidobacterium strains of human origin for potential use in probiotic functional foods.
    Souza TC; Silva AM; Drews JR; Gomes DA; Vinderola CG; Nicoli JR
    Benef Microbes; 2013 Jun; 4(2):179-86. PubMed ID: 23443950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of tet(W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans.
    Flórez AB; Ammor MS; Alvarez-Martín P; Margolles A; Mayo B
    Appl Environ Microbiol; 2006 Nov; 72(11):7377-9. PubMed ID: 16936047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety assessment of potential lactic acid bacteria Bifidobacterium longum SPM1205 isolated from healthy Koreans.
    Choi SS; Kang BY; Chung MJ; Kim SD; Park SH; Kim JS; Kang CY; Ha NJ
    J Microbiol; 2005 Dec; 43(6):493-8. PubMed ID: 16410764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences in fecal Bifidobacterium species between patients with type 2 diabetes and healthy individuals].
    Xu X; Hui H; Cai D
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):531-3, 564. PubMed ID: 22543136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of eight antibiotics against Pseudomonas aeruginosa and infrequently isolated gram-negative bacilli.
    Chiaradia V; Pascoli L; Santini G
    Chemioterapia; 1985 Aug; 4(4):284-8. PubMed ID: 3931923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of faecal bifidobacteria and lactobacilli isolated from dogs and primates.
    Strompfová V; Lauková A
    Anaerobe; 2014 Oct; 29():108-12. PubMed ID: 24239978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of CI-934 and other antimicrobial agents against gram-positive and gram-negative bacteria.
    Smith RP; Baltch AL; Hammer MC; Conroy JV
    Clin Ther; 1986; 9(1):106-18. PubMed ID: 3815456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between aerobic fecal and oropharyngeal microflora in hospitalized patients.
    LeFrock JL; Ellis CA; Weinstein L
    Am J Med Sci; 1979; 277(3):275-80. PubMed ID: 453232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of ceftriaxone on bacterial flora in human feces].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
    Jpn J Antibiot; 1985 Oct; 38(10):2770-96. PubMed ID: 4078993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic activity against pathological genito urinary and enteric gram negative rods as observed in 1983. At Public Health Laboratory, Mutare General Hospital, Zimbabwe.
    Kambaza A; Mutsaka P
    Cent Afr J Med; 1984 Oct; 30(10):195-7. PubMed ID: 6518492
    [No Abstract]   [Full Text] [Related]  

  • 16. Species of the genus Bifidobacterium in the feces of human adults.
    Biavati B; Castagnoli P; Trovatelli LD
    Microbiologica; 1986 Jan; 9(1):39-45. PubMed ID: 3951366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selective inhibitory effect of 8-hydroxyquinoline against bifidobacteria and clostridia.
    Novakova J; Vlkova E; Bonusova B; Rada V; Kokoska L
    Anaerobe; 2013 Aug; 22():134-6. PubMed ID: 23770542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial peptides and the outer membranes of gram-negative bacilli.
    Hancock RE
    J Med Microbiol; 1997 Jan; 46(1):1-3. PubMed ID: 9003734
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-fermentative Gram-negative bacilli of human origin. II. In vitro sensitivity of 185 strains to 17 anti-microbial agents].
    Paredes L; Thompson L; del Canto E; Paredes L
    Rev Med Chil; 1985 Sep; 113(9):878-85. PubMed ID: 3837315
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of subtherapeutic chlortetracycline on antimicrobial resistance in the fecal flora of swine.
    Funk JA; Lejeune JT; Wittum TE; Rajala-Schultz PJ
    Microb Drug Resist; 2006; 12(3):210-8. PubMed ID: 17002549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.